2024年《中国高血压临床实践指南》核心要点解读  

Interpretation of the core points of the clinical practice guidelines for the management of hypertension in China(2024)

作　　者：王运红 邓启明 蔡军 WANG Yunhong;DENG Qiming;CAI Jun(Hypertension Center,Anzhen Hospital,Capital Medical University,Beijing 100029,China;不详)

机构地区：[1]首都医科大学附属北京安贞医院高血压中心一区,北京100029 [2]首都医科大学附属北京安贞医院,北京100029

出　　处：《中国预防医学杂志》2025年第2期133-142,共10页Chinese Preventive Medicine

摘　　要：2024年9月,中华医学会心血管病学分会、海峡两岸医药卫生交流协会高血压专业委员会、中国康复医学会心血管疾病预防与康复专业委员会联合发布了《中国高血压临床实践指南》(以下简称“指南”)。该指南纳入与高血压防治管理密切相关的44个关键临床问题,形成了98条推荐意见。本文提炼出指南的九大核心要点进行深入解读,以期帮助广大医生更好地理解指南的核心内容。In September 2024,the Chinese Society of Cardiology,Chinese Medical Association,the Hypertension Committee of Cross-Straits Medicine Exchange Association,and the Cardiovascular Disease Prevention and Rehabilitation Committee,Chinese Association of Rehabilitation Medicine jointly released the"Clinical Practice Guidelines for the Management of Hypertension in China".This guideline includes 44 critical clinical issues closely related to the prevention and management of hypertension,resulting in 98 recommendations.This article extracts and interprets the nine core points of the guidelines in depth,aiming to help physicians better understand the essential content of the guidelines.

关 键 词：高血压 指南 核心要点 解读 

分 类 号：R544.1[医药卫生—心血管疾病]